ICD-O coding of paediatric tumours 
ICD-O topographical coding of paediatric tumours
The ICD-O topography codes for the main anatomical sites covered in this volume are as follows [[Fritz A, Percy C, Jack A, et al., editors. International classification of diseases for oncology (ICD-O). 3rd ed. 1st rev. Geneva (Switzerland): World Health Organization; 2013.]]:

C00–C14 Lip, oral cavity, and pharynx

C00 Lip

     C00.0 External upper lip

     C00.1 External lower lip

     C00.2 External lip, NOS

     C00.3 Mucosa of upper lip

     C00.4 Mucosa of lower lip

     C00.5 Mucosa of lip, NOS

     C00.6 Commissure of lip

     C00.8 Overlapping lesion of lip

     C00.9 Lip, NOS

C01 Base of tongue

     C01.9 Base of tongue, NOS

C02 Other and unspecified parts of tongue

     C02.0 Dorsal surface of tongue, NOS

     C02.1 Border of tongue

     C02.2 Ventral surface of tongue, NOS

     C02.3 Anterior two thirds of tongue, NOS

     C02.4 Lingual tonsil

     C02.8 Overlapping lesion of tongue

     C02.9 Tongue, NOS

C03 Gum

     C03.0 Upper gum

     C03.1 Lower gum

     C03.9 Gum, NOS

C04 Floor of mouth

     C04.0 Anterior floor of mouth

     C04.1 Lateral floor of mouth

     C04.8 Overlapping lesion of floor of mouth

     C04.9 Floor of mouth, NOS

C05 Palate

     C05.0 Hard palate

     C05.1 Soft palate, NOS

     C05.2 Uvula

     C05.8 Overlapping lesion of palate

     C05.9 Palate, NOS

C06 Other and unspecified parts of mouth

     C06.0 Cheek mucosa

     C06.1 Vestibule of mouth

     C06.2 Retromolar area

     C06.8 Overlapping lesion of other and unspecified parts of mouth

     C06.9 Mouth, NOS

C07 Parotid gland

     C07.9 Parotid gland

C08 Other and unspecified major salivary glands

     C08.0 Submandibular gland

     C08.1 Sublingual gland

     C08.8 Overlapping lesion of major salivary glands

     C08.9 Major salivary gland, NOS

C09 Tonsil

     C09.0 Tonsillar fossa

     C09.1 Tonsillar pillar

     C09.8 Overlapping lesion of tonsil

     C09.9 Tonsil, NOS

C10 Oropharynx

     C10.0 Vallecula

     C10.1 Anterior surface of epiglottis

     C10.2 Lateral wall of oropharynx

     C10.3 Posterior wall of oropharynx

     C10.4 Branchial cleft

     C10.8 Overlapping lesion of oropharynx

     C10.9 Oropharynx, NOS

C11 Nasopharynx

     C11.0 Superior wall of nasopharynx

     C11.1 Posterior wall of nasopharynx

     C11.2 Lateral wall of nasopharynx

     C11.3 Anterior wall of nasopharynx

     C11.8 Overlapping lesion of nasopharynx

     C11.9 Nasopharynx, NOS

C12 Piriform sinus

     C12.9 Piriform sinus

C13 Hypopharynx

     C13.0 Postcricoid region

     C13.1 Hypopharyngeal aspect of aryepiglottic fold

     C13.2 Posterior wall of hypopharynx

     C13.8 Overlapping lesion of hypopharynx

     C13.9 Hypopharynx, NOS

C14 Other and ill-defined sites in lip, oral cavity, and pharynx

     C14.0 Pharynx, NOS

     C14.2 Waldeyer ring

     C14.8 Overlapping lesion of lip, oral cavity, and pharynx

C15–C26 Digestive organs

C15 Oesophagus

     C15.0 Cervical oesophagus

     C15.1 Thoracic oesophagus

     C15.2 Abdominal oesophagus

     C15.3 Upper third of oesophagus

     C15.4 Middle third of oesophagus

     C15.5 Lower third of oesophagus

     C15.8 Overlapping lesion of oesophagus

     C15.9 Oesophagus, NOS

C16 Stomach

     C16.0 Cardia, NOS

     C16.1 Fundus of stomach

     C16.2 Body of stomach

     C16.3 Gastric antrum

     C16.4 Pylorus

     C16.5 Lesser curvature of stomach, NOS

     C16.6 Greater curvature of stomach, NOS

     C16.8 Overlapping lesion of stomach

     C16.9 Stomach, NOS

C17 Small intestine

     C17.0 Duodenum

     C17.1 Jejunum

     C17.2 Ileum

     C17.3 Meckel diverticulum

     C17.8 Overlapping lesion of small intestine

     C17.9 Small intestine, NOS

C18 Colon

     C18.0 Cecum

     C18.1 Appendix

     C18.2 Ascending colon

     C18.3 Hepatic flexure of colon

     C18.4 Transverse colon

     C18.5 Splenic flexure of colon

     C18.6 Descending colon

     C18.7 Sigmoid colon

     C18.8 Overlapping lesion of colon

     C18.9 Colon, NOS

C19 Rectosigmoid junction

     C19.9 Rectosigmoid junction

C20 Rectum

     C20.9 Rectum, NOS

C21 Anus and anal canal

     C21.0 Anus, NOS

     C21.1 Anal canal

     C21.2 Cloacogenic zone

     C21.8 Overlapping lesion of rectum, anus, and anal canal

C22 Liver and intrahepatic bile ducts

     C22.0 Liver

     C22.1 Intrahepatic bile duct

C23 Gallbladder

     C23.9 Gallbladder

C24 Other and unspecified parts of biliary tract

     C24.0 Extrahepatic bile duct

     C24.1 Ampulla of Vater

     C24.8 Overlapping lesion of biliary tract

     C24.9 Biliary tract, NOS

C25 Pancreas

     C25.0 Head of pancreas

     C25.1 Body of pancreas

     C25.2 Tail of pancreas

     C25.3 Pancreatic duct

     C25.4 Islets of Langerhans

     C25.7 Other specified parts of pancreas

     C25.8 Overlapping lesion of pancreas

     C25.9 Pancreas, NOS

C26 Other and ill-defined digestive organs

     C26.0 Intestinal tract, NOS

     C26.8 Overlapping lesion of digestive system

     C26.9 Gastrointestinal tract, NOS

 

C30–C39 Respiratory system and intrathoracic organs

C30 Nasal cavity and middle ear

     C30.0 Nasal cavity

     C30.1 Middle ear

C31 Accessory sinuses

     C31.0 Maxillary sinus

     C31.1 Ethmoid sinus

     C31.2 Frontal sinus

     C31.3 Sphenoid sinus

     C31.8 Overlapping lesion of accessory sinuses

     C31.9 Accessory sinus, NOS

C32 Larynx

     C32.0 Glottis

     C32.1 Supraglottis

     C32.2 Subglottis

     C32.3 Laryngeal cartilage

     C32.8 Overlapping lesion of larynx

     C32.9 Larynx, NOS

C33 Trachea

     C33.9 Trachea

C34 Bronchus and lung

     C34.0 Main bronchus

     C34.1 Upper lobe, lung

     C34.2 Middle lobe, lung

     C34.3 Lower lobe, lung

     C34.8 Overlapping lesion of lung

     C34.9 Lung, NOS

C37 Thymus

     C37.9 Thymus

C38 Heart, mediastinum, and pleura

     C38.0 Heart

     C38.1 Anterior mediastinum

     C38.2 Posterior mediastinum

     C38.3 Mediastinum, NOS

     C38.4 Pleura, NOS

     C38.8 Overlapping lesion of heart, mediastinum, and pleura

C39 Other and ill-defined sites within respiratory system and intrathoracic organs

     C39.0 Upper respiratory tract, NOS

     C39.8 Overlapping lesion of respiratory system and intrathoracic organs

     C39.9 Ill-defined sites within respiratory system

C40–C41 Bones, joints, and articular cartilage

C40 Bones, joints, and articular cartilage of limbs

     C40.0 Long bones of upper limb, scapula, and associated joints

     C40.1 Short bones of upper limb and associated joints

     C40.2 Long bones of lower limb and associated joints

     C40.3 Short bones of lower limb and associated joints

     C40.8 Overlapping lesion of bones, joints, and articular cartilage of limbs

     C40.9 Bone of limb, NOS

C41 Bones, joints, and articular cartilage of other and unspecified sites

     C41.0 Bones of skull and face and associated joints

     C41.1 Mandible

     C41.2 Vertebral column

     C41.3 Rib, sternum, clavicle, and associated joints

     C41.4 Pelvic bones, sacrum, coccyx, and associated joints

     C41.8 Overlapping lesion of bones, joints, and articular cartilage

     C41.9 Bone, NOS

C42 Haematopoietic and reticuloendothelial systems

     C42.0 Blood

     C42.1 Bone marrow

     C42.2 Spleen

     C42.3 Reticuloendothelial system, NOS

     C42.4 Haematopoietic system, NOS

C44 Skin

     C44.0 Skin of lip, NOS

     C44.1 Eyelid

     C44.2 External ear

     C44.3 Skin of other and unspecified parts of face

     C44.4 Skin of scalp and neck

     C44.5 Skin of trunk

     C44.6 Skin of upper limb and shoulder

     C44.7 Skin of lower limb and hip

     C44.8 Overlapping lesion of skin

     C44.9 Skin, NOS

C47 Peripheral nerves and autonomic nervous system

     C47.0 Peripheral nerves and autonomic nervous system of head, face, and neck

     C47.1 Peripheral nerves and autonomic nervous system of upper limb and shoulder

     C47.2 Peripheral nerves and autonomic nervous system of lower limb and hip

     C47.3 Peripheral nerves and autonomic nervous system of thorax

     C47.4 Peripheral nerves and autonomic nervous system of abdomen

     C47.5 Peripheral nerves and autonomic nervous system of pelvis

     C47.6 Peripheral nerves and autonomic nervous system of trunk, NOS

     C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system

     C47.9 Autonomic nervous system, NOS

C48 Retroperitoneum and peritoneum

     C48.0 Retroperitoneum

     C48.1 Specified parts of peritoneum

     C48.2 Peritoneum, NOS

     C48.8 Overlapping lesion of retroperitoneum and peritoneum

C49 Connective, subcutaneous, and other soft tissues

     C49.0 Connective, subcutaneous, and other soft tissues of head, face, and neck

     C49.1 Connective, subcutaneous, and other soft tissues of upper limb and shoulder

     C49.2 Connective, subcutaneous, and other soft tissues of lower limb and hip

     C49.3 Connective, subcutaneous, and other soft tissues of thorax

     C49.4 Connective, subcutaneous, and other soft tissues of abdomen

     C49.5 Connective, subcutaneous, and other soft tissues of pelvis

     C49.6 Connective, subcutaneous, and other soft tissues of trunk, NOS

     C49.8 Overlapping lesion of connective, subcutaneous, and other soft tissues

     C49.9 Connective, subcutaneous, and other soft tissues, NOS

C50 Breast

     C50.0 Nipple

     C50.1 Central portion of breast

     C50.2 Upper-inner quadrant of breast

     C50.3 Lower-inner quadrant of breast

     C50.4 Upper-outer quadrant of breast

     C50.5 Lower-outer quadrant of breast

     C50.6 Axillary tail of breast

     C50.8 Overlapping lesion of breast

     C50.9 Breast, NOS

C51–C58 Female genital organs

C51 Vulva

     C51.0 Labium majus

     C51.1 Labium minus

     C51.2 Clitoris

     C51.8 Overlapping lesion of vulva

     C51.9 Vulva, NOS

C52 Vagina

     C52.9 Vagina, NOS

C53 Cervix uteri

     C53.0 Endocervix

     C53.1 Exocervix

     C53.8 Overlapping lesion of cervix uteri

     C53.9 Cervix uteri

C54 Corpus uteri

     C54.0 Isthmus uteri

     C54.1 Endometrium

     C54.2 Myometrium

     C54.3 Fundus uteri

     C54.8 Overlapping lesion of corpus uteri

     C54.9 Corpus uteri

C55 Uterus, NOS

     C55.9 Uterus, NOS

C56 Ovary

     C56.9 Ovary

C57 Other and unspecified female genital organs

     C57.0 Fallopian tube

     C57.1 Broad ligament

     C57.2 Round ligament

     C57.3 Parametrium

     C57.4 Uterine adnexa

     C57.7 Other specified parts of female genital organs

     C57.8 Overlapping lesion of female genital organs

     C57.9 Female genital tract, NOS

C58 Placenta

     C58.9 Placenta

C60–C63 Male genital organs

C60 Penis

     C60.0 Prepuce

     C60.1 Glans penis

     C60.2 Body of penis

     C60.8 Overlapping lesion of penis

     C60.9 Penis, NOS

C61 Prostate gland

     C61.9 Prostate gland

C62 Testis

     C62.0 Undescended testis

     C62.1 Descended testis

     C62.9 Testis, NOS

C63 Other and unspecified male genital organs

     C63.0 Epididymis

     C63.1 Spermatic cord

     C63.2 Scrotum, NOS

     C63.7 Other specified parts of male genital organs

     C63.8 Overlapping lesion of male genital organs

     C63.9 Male genital organs, NOS

C64–C68 Urinary tract

C64 Kidney

     C64.9 Kidney, NOS

C65 Renal pelvis

     C65.9 Renal pelvis

C66 Ureter

     C66.9 Ureter

C67 Bladder

     C67.0 Trigone of bladder

     C67.1 Dome of bladder

     C67.2 Lateral wall of bladder

     C67.3 Anterior wall of bladder

     C67.4 Posterior wall of bladder

     C67.5 Bladder neck

     C67.6 Ureteric orifice

     C67.7 Urachus

     C67.8 Overlapping lesion of bladder

     C67.9 Bladder, NOS

C68 Other and unspecified urinary organs

     C68.0 Urethra

     C68.1 Paraurethral gland

     C68.8 Overlapping lesion of urinary organs

     C68.9 Urinary system, NOS

C69–C72 Eye, brain, and other parts of central nervous system

C69 Eye and adnexa

     C69.0 Conjunctiva

     C69.1 Cornea, NOS

     C69.2 Retina

     C69.3 Choroid

     C69.4 Ciliary body

     C69.5 Lacrimal gland

     C69.6 Orbit, NOS

     C69.8 Overlapping lesion of eye and adnexa

     C69.9 Eye, NOS

C70 Meninges

     C70.0 Cerebral meninges

     C70.1 Spinal meninges

     C70.9 Meninges, NOS

C71 Brain

     C71.0 Cerebrum

     C71.1 Frontal lobe

     C71.2 Temporal lobe

     C71.3 Parietal lobe

     C71.4 Occipital lobe

     C71.5 Ventricle, NOS

     C71.6 Cerebellum, NOS

     C71.7 Brain stem

     C71.8 Overlapping lesion of brain

     C71.9 Brain, NOS

C72 Spinal cord, cranial nerves, and other parts of central nervous system

     C72.0 Spinal cord

     C72.1 Cauda equina

     C72.2 Olfactory nerve

     C72.3 Optic nerve

     C72.4 Acoustic nerve

     C72.5 Cranial nerve, NOS

     C72.8 Overlapping lesion of brain and central nervous system

     C72.9 Nervous system, NOS

C73–C75 Thyroid and other endocrine glands

C73 Thyroid gland

     C73.9 Thyroid gland

C74 Adrenal gland

     C74.0 Cortex of adrenal gland

     C74.1 Medulla of adrenal gland

     C74.9 Adrenal gland, NOS

C75 Other endocrine glands and related structures

     C75.0 Parathyroid gland

     C75.1 Pituitary gland

     C75.2 Craniopharyngeal duct

     C75.3 Pineal gland

     C75.4 Carotid body

     C75.5 Aortic body and other paraganglia

     C75.8 Overlapping lesion of endocrine glands and related structures

     C75.9 Endocrine gland, NOS

C76 Other and ill-defined sites

     C76.0 Head, face, or neck, NOS

     C76.1 Thorax, NOS

     C76.2 Abdomen, NOS

     C76.3 Pelvis, NOS

     C76.4 Upper limb, NOS

     C76.5 Lower limb, NOS

     C76.7 Other ill-defined sites

     C76.8 Overlapping lesion of ill-defined sites

C77 Lymph nodes

     C77.0 Lymph nodes of head, face, and neck

     C77.1 Intrathoracic lymph nodes

     C77.2 Intra-abdominal lymph nodes

     C77.3 Lymph nodes of axilla or arm

     C77.4 Lymph nodes of inguinal region or leg

     C77.5 Pelvic lymph nodes

     C77.8 Lymph nodes of multiple regions

     C77.9 Lymph node, NOS

C80 Unknown primary site

     C80.9 Unknown primary site

ICD-O morphological coding: Introduction
The ICD-O coding system uses a topography (T) code and a morphology (M) code together, but these are presented in separate lists for ease of use. Behaviour is coded /0 for benign tumours; /1 for unspecified, borderline, or uncertain behaviour; /2 for carcinoma in situ and grade III intraepithelial neoplasia; /3 for malignant tumours, primary site; and /6 for malignant tumours, metastatic site. Behaviour code /6 is not generally used by cancer registries. For various reasons, the ICD-O morphology terms may not always be identical to the entity names used in the WHO classification, but they should be sufficiently similar to avoid confusion. The designation “NOS” (“not otherwise specified”) is provided to make coding possible when subtypes exist but exact classification may not be possible in small biopsies or certain other scenarios. Therefore, it is usual to have “NOS” even when a more specific alternative term is listed in ICD-O.

 

ICD-O coding of haematolymphoid disorders
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Myeloid neoplasms

Myeloproliferative neoplasms

9875/3          Chronic myeloid leukaemia (CML), BCR::ABL1

 

Myelodysplastic/myeloproliferative neoplasms

9946/3          Juvenile myelomonocytic leukaemia (JMML)

9946/3                    PTPN11-mutated JMML†

9946/3                    NRAS-mutated JMML†

9946/3                    KRAS-mutated JMML†

9946/3                    JMML in neurofibromatosis type 1 (NF1)†

9946/3                    JMML in children with CBL syndrome†

9946/3                    JMML-like disorders in children with Noonan syndrome (NS)†

 

Myelodysplastic syndromes

9985/3          Refractory cytopenia of childhood

9983/3          Myelodysplastic syndrome with excess blasts

 

Acute myeloid leukaemias (AMLs) defined by differentiation

9861/3          Acute myeloid leukaemia (AML), NOS

9872/3                    AML with minimal differentiation

9873/3                    AML without maturation

9874/3                    AML with maturation

9867/3                    Acute myelomonocytic leukaemia

9891/3                    Acute monocytic leukaemia

9840/3                    Acute erythroid leukaemia

9910/3                    Acute megakaryoblastic leukaemia

 

Acute myeloid leukaemias (AMLs) with defining genetic abnormalities

9866/3                    Acute promyelocytic leukaemia with PML::RARA fusion

9896/3                    AML with RUNX1::RUNX1T1 fusion†

9871/3                    AML with CBFB::MYH11 fusion

9897/3                    AML with KMT2A rearrangement†

9877/3                    AML with NPM1 mutation

9869/3                    AML with MECOM rearrangement†

9865/3                    AML with DEK::NUP214 fusion

9911/3                    AML with RBM15::MRTFA fusion

9912/3                    AML with BCR::ABL1 fusion

9861/3                    AML with NUP98 rearrangement†

9878/3                    AML with CEBPA mutation

9861/3                    AML with MNX1::ETV6 fusion†

9861/3                    AML with KAT6A::CREBBP fusion†

9861/3                    AML with CBFA2T3::GLIS2 fusion†

 

Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions

                     Myeloid neoplasms associated with germline predisposition (code according to underlying condition)

                     Myeloid proliferations associated with Down syndrome

9898/1                    Transient abnormal myelopoiesis

9898/3                    Myeloid leukaemia associated with Down syndrome

 

Mast cell neoplasia

                     Mastocytosis

9740/1                    Cutaneous mastocytosis

9741/1                    Indolent systemic mastocytosis

9741/3                    Aggressive systemic mastocytosis

9742/3                    Mast cell leukaemia

9740/3                    Mast cell sarcoma

9741/3                    Systemic mastocytosis with an associated haematological neoplasm†

 

Lymphoid neoplasms

Precursor lymphoid neoplasms

9811/3          B-lymphoblastic leukaemia (B-ALL), NOS

                     B-lymphoblastic leukaemia (B-ALL) with recurrent genetic alterations

9814/3                    B-ALL with ETV6::RUNX1 fusion†

9814/3                    B-ALL with ETV6::RUNX1-like features (provisional subtype)†

9819/3                    B-ALL with BCR::ABL1-like (Ph-like) features

9818/3                    B-ALL with TCF3::PBX1 fusion

9815/3                    B-ALL with high hyperdiploidy†

9816/3                    B-ALL with near-haploidy†

9816/3                    B-ALL with low hypodiploidy†

9816/3                    B-ALL with high hypodiploidy†

9817/3                    B-ALL with IGH::IL3 fusion

9812/3                    B-ALL with BCR::ABL1 fusion

9818/3                    B-ALL with TCF3::HLF fusion†

9813/3                    B-ALL with KMT2A rearrangement†

9811/3                    B-ALL with iAMP21

9811/3                    B-ALL with DUX4 rearrangement†

9811/3                    B-ALL with MEF2D rearrangement†

9811/3                    B-ALL with ZNF384 rearrangement†

9811/3                    B-ALL with PAX5 alteration†

9811/3                    B-ALL with PAX5 p.P80R variant†

9811/3                    B-ALL with NUTM1 rearrangement†

                     T- and NK-cell lymphoblastic leukaemia/lymphoma

9837/3                    T-lymphoblastic leukaemia/lymphoma

9837/3                    Early T-precursor lymphoblastic leukaemia/lymphoma

9835/3                    NK-lymphoblastic leukaemia/lymphoma†

 

Mature B-cell neoplasms

9679/3          Mediastinal large B-cell lymphoma

9680/3          Diffuse large B-cell lymphoma (DLBCL), NOS

9680/3                    DLBCL, germinal-centre B-cell subtype

9680/3                    DLBCL, activated B-cell subtype

9680/3          EBV-positive diffuse large B-cell lymphoma

9698/3          Large B-cell lymphoma with IRF4 rearrangement

9690/3          Paediatric-type follicular lymphoma

9699/3          Paediatric nodal marginal zone B-cell lymphoma†

9737/3          ALK-positive large B-cell lymphoma

9766/1          Lymphomatoid granulomatosis, grade 1

9766/1          Lymphomatoid granulomatosis, grade 2

9766/3          Lymphomatoid granulomatosis, grade 3

9735/3          Plasmablastic lymphoma

9596/3          Mediastinal grey zone lymphoma

9687/3          Burkitt lymphoma

9687/3                    Endemic Burkitt lymphoma†

9687/3                    Sporadic Burkitt lymphoma†

9687/3                    Immunodeficiency-associated Burkitt lymphoma†

9687/3          High-grade B-cell lymphoma with 11q aberration†

 

Mature T/NK-cell neoplasms

9702/3          Peripheral T-cell lymphoma

9948/3          Aggressive NK-cell leukaemia

 

Primary cutaneous T-cell neoplasms: Mycosis fungoides

9700/3          Mycosis fungoides

9700/3                    Hypopigmented mycosis fungoides†

9700/3                    Adnexotropic (folliculotropic and/or syringotropic) mycosis fungoides†

9700/3                    Pagetoid reticulosis (Woringer–Kolopp type)†

9700/3                    Granulomatous slack skin disease

 

Primary cutaneous CD30-positive T-cell lymphoproliferative disorders

9718/1          Lymphomatoid papulosis

9718/1                    Primary mucosal CD30-positive T-cell lymphoproliferative disorder†

9718/1                    Lymphomatoid papulosis type A†

9718/1                    Lymphomatoid papulosis type B†

9718/1                    Lymphomatoid papulosis type C†

9718/1                    Lymphomatoid papulosis type D†

9718/1                    Lymphomatoid papulosis type E†

9718/1                    Lymphomatoid papulosis with DUSP22 locus rearrangement†

9718/3          Primary cutaneous anaplastic large cell lymphoma

 

Primary cutaneous T-cell neoplasms: Subcutaneous panniculitis-like T-cell lymphoma

9708/3          Subcutaneous panniculitis-like T-cell lymphoma

 

Anaplastic large cell lymphoma

9714/3          Anaplastic large cell lymphoma, ALK-positive (ALK+ ALCL)

9714/3                    Common ALK+ ALCL†

9714/3                    Small cell ALK+ ALCL†

9714/3                    Lymphohistiocytic ALK+ ALCL†

9714/3                    Hodgkin-like ALK+ ALCL†

9714/3                    Composite ALK+ ALCL†

 

Hepatosplenic T-cell lymphoma

9716/3          Hepatosplenic T-cell lymphoma

 

EBV-positive lymphoproliferative diseases of childhood

9724/3          Systemic EBV-positive T-cell lymphoma of childhood†

9725/1          Hydroa vacciniforme lymphoproliferative disorder†

9725/1                    Classic hydroa vacciniforme lymphoproliferative disorder†

9725/1                    Systemic hydroa vacciniforme lymphoproliferative disorder†

 

Hodgkin lymphoma

9650/3          Classic Hodgkin lymphoma (CHL), NOS

9663/3                    Nodular sclerosis CHL

9651/3                    Lymphocyte-rich CHL

9652/3                    Mixed-cellularity CHL

9653/3                    Lymphocyte-depleted CHL

9659/3          Nodular lymphocyte-predominant Hodgkin lymphoma

 

Histiocytic and dendritic cell neoplasms

Langerhans cell histiocytosis and related disorders

9751/1          Langerhans cell histiocytosis, NOS

9751/3          Langerhans cell histiocytosis, disseminated

9749/3          Erdheim–Chester disease

9749/1          Juvenile xanthogranuloma

9749/3          Rosai–Dorfman disease

 

Immunodeficiency-associated lymphoproliferative disorders

Primary immunodeficiency–associated lymphoproliferative disorders

                     Code as disorder

 

Posttransplant lymphoproliferative disorders

9971/1          Posttransplant lymphoproliferative disorder (PTLD), NOS

None                      Non-destructive hyperplastic PTLD

9971/1                    Polymorphic PTLDs

                               Monomorphic PTLDs (code as disorder)

 

HIV-associated lymphoproliferative disorders

                     Code as disorder

 

ICD-O coding of CNS tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Gliomas, glioneuronal tumours, and neuronal tumours

Paediatric-type diffuse low-grade gliomas

9421/1          Diffuse astrocytoma, MYB- or MYBL1-altered

9421/1                    Diffuse astrocytoma, MYB-altered†

9421/1                    Diffuse astrocytoma, MYBL1-altered†

9431/1          Angiocentric glioma

9413/0          Polymorphous low-grade neuroepithelial tumour of the young

9421/1          Diffuse low-grade glioma, MAPK pathway–altered

9421/1                    Diffuse low-grade glioma, FGFR1 tyrosine kinase domain–duplicated†

9421/1                    Diffuse low-grade glioma, FGFR1-mutant†

9421/1                    Diffuse low-grade glioma, BRAF p.V600E–mutant†

 

Paediatric-type diffuse high-grade gliomas

9385/3          Diffuse midline glioma, H3 K27–altered

9385/3                    Diffuse midline glioma, H3.3 K27–mutant†

9385/3                    Diffuse midline glioma, H3.1 or H3.2 K27–mutant†

9385/3                    Diffuse midline glioma, H3-wildtype with EZHIP overexpression†

9385/3                    Diffuse midline glioma, EGFR-mutant†

9385/3          Diffuse hemispheric glioma, H3 G34–mutant

9385/3          Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype

9385/3                    Diffuse paediatric-type high-grade glioma RTK2†

9385/3                    Diffuse paediatric-type high-grade glioma RTK1†

9385/3                    Diffuse paediatric-type high-grade glioma MYCN†

9385/3          Infant-type hemispheric glioma

9385/3                    Infant-type hemispheric glioma, NTRK-altered†

9385/3                    Infant-type hemispheric glioma, ROS1-altered†

9385/3                    Infant-type hemispheric glioma, ALK-altered†

9385/3                    Infant-type hemispheric glioma, MET-altered†

 

Circumscribed astrocytic gliomas

9421/1          Pilocytic astrocytoma

9425/3                    Pilomyxoid astrocytoma

9421/1                    Pilocytic astrocytoma with histological features of anaplasia†

9421/3          High-grade astrocytoma with piloid features

9424/3          Pleomorphic xanthoastrocytoma

9384/1          Subependymal giant cell astrocytoma

9430/3          Astroblastoma, MN1-altered

 

Glioneuronal and neuronal tumours

9505/1          Ganglioglioma

9412/1          Desmoplastic infantile ganglioglioma

9412/1          Desmoplastic infantile astrocytoma

9413/0          Dysembryoplastic neuroepithelial tumour

n/a                Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (provisional entity)

9509/3          Diffuse leptomeningeal glioneuronal tumour

9509/3                    Diffuse leptomeningeal glioneuronal tumour with 1q gain†

9509/3                    Diffuse leptomeningeal glioneuronal tumour, methylation class 1 (DLGNT-MC-1)†

9509/3                    Diffuse leptomeningeal glioneuronal tumour, methylation class 2 (DLGNT-MC-2)†

9509/0          Multinodular and vacuolating neuronal tumour

 

Ependymal tumours

9391/3          Supratentorial ependymoma, NOS

9396/3          Supratentorial ependymoma, ZFTA fusion–positive

9396/3          Supratentorial ependymoma, YAP1 fusion–positive

9391/3          Posterior fossa ependymoma, NOS

9396/3          Posterior fossa group A (PFA) ependymoma

9396/3          Posterior fossa group B (PFB) ependymoma

9391/3          Spinal ependymoma, NOS

9396/3          Spinal ependymoma, MYCN-amplified

9394/1          Myxopapillary ependymoma

 

Choroid plexus tumours

9390/0          Choroid plexus papilloma

9390/1          Atypical choroid plexus papilloma

9390/3          Choroid plexus carcinoma

 

CNS embryonal tumours

Medulloblastomas, molecularly defined

9475/3          Medulloblastoma, WNT-activated

9471/3          Medulloblastoma, SHH-activated and TP53-wildtype

9476/3          Medulloblastoma, SHH-activated and TP53-mutant

9477/3          Medulloblastoma, non-WNT/non-SHH

 

Medulloblastomas, histologically defined

                     Medulloblastoma, histologically defined

9470/3                    Classic medulloblastoma

9471/3                    Desmoplastic nodular medulloblastoma

9471/3                    Medulloblastoma with extensive nodularity

9474/3                    Large cell medulloblastoma

9474/3                    Anaplastic medulloblastoma

 

Other CNS embryonal tumours

9508/3          Atypical teratoid/rhabdoid tumour

n/a                Cribriform neuroepithelial tumour (provisional entity)

9478/3          Embryonal tumour with multilayered rosettes

9478/3                    Embryonal tumour with multilayered rosettes, C19MC-altered†

9478/3                    Embryonal tumour with multilayered rosettes, DICER1-mutated†

9500/3          CNS neuroblastoma, FOXR2-activated

9500/3          CNS tumour with BCOR internal tandem duplication

9473/3          CNS embryonal tumour, NEC/NOS

 

Pineal tumours

9362/3          Pineoblastoma

9362/3                    Pineoblastoma, miRNA processing-altered_1†

9362/3                    Pineoblastoma, miRNA processing-altered_2†

9362/3                    Pineoblastoma, RB1-altered (pineal retinoblastoma)†

9362/3                    Pineoblastoma, MYC/FOXR2-activated†

 

Melanocytic CNS tumours

8728/0          Meningeal melanocytosis

8728/3          Meningeal melanomatosis

 

Tumours of the sellar region

Pituitary endocrine tumours

8272/3          Pituitary adenoma / pituitary neuroendocrine tumour (PitNET)

8272/3                    Densely granulated somatotroph tumour†

8272/3                    Sparsely granulated somatotroph tumour†

8271/3*                  Sparsely granulated lactotroph tumour

8271/3*                  Densely granulated lactotroph tumour

8280/3*                  Mammosomatotroph tumour

8272/3                    Thyrotroph tumour

8272/3                    Mature PIT1-lineage tumour†

8280/3*                  Acidophil stem cell tumour

8272/3                    Immature PIT1-lineage tumour†

8272/3                    Densely granulated corticotroph tumour†

8272/3                    Sparsely granulated corticotroph tumour†

8272/3                    Crooke cell tumour†

8272/3                    Gonadotroph tumour†

8272/3                    Unclassified plurihormonal tumours

8272/3                    Null cell tumour

8273/3          Pituitary blastoma

 

Craniopharyngiomas

9351/1          Adamantinomatous craniopharyngioma

 

ICD-O coding of peripheral neuroblastic tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

9490/0          Ganglioneuroma

9490/0                    Maturing ganglioneuroma†

9490/0                    Mature ganglioneuroma†

9490/3          Ganglioneuroblastoma, intermixed†

9500/3          Neuroblastoma, NOS

9500/3                    Undifferentiated neuroblastoma†

9500/3                    Poorly differentiated neuroblastoma†

9500/3                    Differentiating neuroblastoma†

9490/3          Ganglioneuroblastoma, nodular†

 

ICD-O coding of eye tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Conjunctival neoplasms

Hamartomas

                     Epibulbar choristoma

                               Epibulbar dermoid

                               Dermolipoma

                               Complex choristoma

                     Epibulbar osseous choristoma

                     Phakomatous choristoma

 

Melanocytic neoplasms

8740/0          Junctional naevus

8740/0                    Conjunctival junctional / predominantly junctional naevus

8760/0          Compound naevus

8760/0                    Conjunctival compound naevus

8750/0          Subepithelial (stromal) naevus

8750/0                    Conjunctival subepithelial (stromal) naevus

8770/0          Inflamed juvenile naevus

 

Uveal neoplasms

9540/0          Neurofibroma

9490/0          Ganglioneuroma

9490/0                    Ganglioneuroma of the choroid

                     Lisch nodule (iris hamartoma)

 

Retinal and neuroepithelial tumours

9510/0          Retinocytoma

9510/3          Retinoblastoma

9510/3                    Unilateral retinoblastoma†

9510/3                    Bilateral retinoblastoma†

9510/3                    Trilateral retinoblastoma†

                     Medulloepithelioma, benign

9501/0                    Benign non-teratoid medulloepithelioma

9502/0                    Benign teratoid medulloepithelioma

                     Medulloepithelioma, malignant

9501/3                    Malignant non-teratoid medulloepithelioma

9502/3                    Malignant teratoid medulloepithelioma

 

Optic nerve tumours

Pilocytic astrocytoma and other gliomas of the optic nerve

9421/1          Pilocytic astrocytoma

9425/3          Pilomyxoid astrocytoma

9505/1          Ganglioglioma

 

ICD-O coding of soft tissue and bone tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Soft tissue tumours

Adipocytic tumours

                     Lipomatosis, paediatric

                               Congenital infiltrating lipomatosis of the face

                               Diffuse lipomatosis

                               Epiploic lipomatosis

                               Encephalocraniocutaneous lipomatosis

                               Michelin tire baby syndrome

                               PTEN hamartoma of soft tissue

                               PIK3CA-related overgrowth spectrum

                               Naevus lipomatosus superficialis

                               Lipomatosis of nerve

                     Lipomatosis, adult manifestation / acquired

                               Familial multiple lipomatosis

                               Multiple symmetrical lipomatosis

                               Pelvic lipomatosis

                               Steroid lipomatosis

                               HIV lipodystrophy

                     Lipoblastoma/lipoblastomatosis

8881/0                    Lipoblastoma

8881/0                    Lipoblastomatosis

8850/3          Liposarcoma, NOS

8850/1                    Atypical lipomatous tumour

8851/3                    Well-differentiated liposarcoma

8858/3                    Dedifferentiated liposarcoma

8852/3                    Myxoid liposarcoma

8854/3                    Pleomorphic liposarcoma

8859/3                    Myxoid pleomorphic liposarcoma

 

Fibroblastic and myofibroblastic tumours

8828/0          Nodular fasciitis†

8828/0                    Cranial fasciitis†

8828/0                    Intravascular fasciitis

8828/0          Proliferative fasciitis

8828/0          Proliferative myositis

                     Myositis ossificans

9180/0*        Fibro-osseous tumour of digits

                     Fibrodysplasia ossificans progressiva

8813/0          Fibroma of tendon sheath

8810/0          Gardner fibroma

8992/0          Fibrous hamartoma of infancy

8851/1          Lipofibromatosis

                     Inclusion body infantile digital fibromatosis

                     Juvenile hyaline fibromatosis (hyaline fibromatosis syndrome)

                     Fibromatosis colli

8816/0          Calcifying aponeurotic fibroma

9160/0          Sinonasal angiofibroma

8813/1          Palmar/plantar fibromatoses

8832/1          Dermatofibrosarcoma protuberans, NOS

8834/1                    Giant cell fibroblastoma

8833/1                    Pigmented dermatofibrosarcoma protuberans

8832/3                    Dermatofibrosarcoma protuberans, fibrosarcomatous

8832/1                    Myxoid dermatofibrosarcoma protuberans†

8832/1                    Dermatofibrosarcoma protuberans with myoid differentiation†

8832/1                    Plaque-like dermatofibrosarcoma protuberans†

                     Desmoid fibromatosis

8821/1                    Extra-abdominal desmoid

8822/1                    Abdominal fibromatosis

8810/0          EWSR1::SMAD3-rearranged fibroblastic tumour†

8814/3          Infantile fibrosarcoma

n/a                Paediatric NTRK-rearranged spindle cell neoplasm (provisional entity)

8840/3          Low-grade fibromyxoid sarcoma

8840/3          Sclerosing epithelioid fibrosarcoma

8825/1          Inflammatory myofibroblastic tumour

8825/1                    Epithelioid inflammatory myofibroblastic sarcoma

8825/3          Low-grade myofibroblastic sarcoma

 

So-called fibrohistiocytic tumours

8830/0          Fibrous histiocytoma

8830/0                    Cellular fibrous histiocytoma†

8830/0                    Aneurysmal fibrous histiocytoma†

8830/1                    Atypical fibrous histiocytoma

8830/0          Epithelioid fibrous histiocytoma

8831/0          Deep fibrous histiocytoma†

8835/1          Plexiform fibrohistiocytic tumour

9252/0          Tenosynovial giant cell tumour, NOS

9252/1                    Tenosynovial giant cell tumour, diffuse

 

Vascular tumours

                     Capillary malformations

                               Naevus simplex

                     Venous malformations

                               Common venous malformation

                               Blue rubber bleb naevus syndrome

                               Glomuvenous malformation

                               Verrucous venous malformation

                               Genuine diffuse phlebectasia of Bockenheimer

9123/0          Arteriovenous malformation

9123/0                    Sporadic arteriovenous malformation†

9123/0                    Arteriovenous malformation occurring in Parkes Weber syndrome†

9123/0                    Arteriovenous malformation occurring in capillary malformation–arteriovenous malformation†

9123/0                    Arteriovenous malformation occurring in hereditary haemorrhagic telangiectasia†

                     Intramuscular vascular anomalies

9132/0                    Intramuscular haemangioma

                               Venous malformation

                               Fibroadipose vascular anomaly

                               Intramuscular fast-flow vascular anomaly

9123/0                    Arteriovenous malformation

                               PTEN hamartoma of soft tissue

                     Lymphatic anomalies

9170/0                    Lymphangioma, NOS

                               Common (cystic) lymphatic malformation

                               Generalized lymphatic anomaly

                               Central conduction lymphatic anomaly, also known as channel-type lymphatic malformation

                               Kaposiform lymphangiomatosis

                               Primary lymphoedema

9131/0          Congenital haemangioma

9131/0                    Rapidly involuting congenital haemangioma with fetal involution†

9131/0                    Rapidly involuting congenital haemangioma†

9131/0                    Partially involuting congenital haemangioma

9131/0                    Non-involuting congenital haemangioma

9131/0          Infantile haemangioma

9131/0                    Reticular infantile haemangioma†

                     Haemangioma of placenta

9131/0          Lobular capillary haemangioma / pyogenic granuloma

9131/0                    Disseminated lobular capillary haemangioma†

9131/0                    Subcutaneous lobular capillary haemangioma†

9131/0                    Intravascular lobular capillary haemangioma†

9125/0          Epithelioid haemangioma

9125/0                    Cellular epithelioid haemangioma†

9125/0                    Atypical epithelioid haemangioma†

9125/0                    Intravascular epithelioid haemangioma†

9161/0          Acquired tufted haemangioma

9130/1          Kaposiform haemangioendothelioma

9135/1          Papillary intralymphatic angioendothelioma

9136/1          Retiform haemangioendothelioma

9138/1          Pseudomyogenic haemangioendothelioma

9140/3          Kaposi sarcoma

9140/3                    Endemic Kaposi sarcoma

9140/3                    Epidemic Kaposi sarcoma

9140/3                    Iatrogenic/transplantation-related Kaposi sarcoma

9140/3                    Sporadic/immunodeficiency-related Kaposi sarcoma

9133/3          Epithelioid haemangioendothelioma, NOS

9133/3                    Epithelioid haemangioendothelioma with WWTR1::CAMTA1 fusion†

9133/3                    Epithelioid haemangioendothelioma with YAP1::TFE3 fusion†

9120/3          Angiosarcoma

 

Pericytic (perivascular) tumours

                     Myofibroma

8824/0                    Solitary myofibroma†

8824/1                    Multicentric myofibromatosis†

8824/1                    Generalized myofibromatosis (with visceral involvement)†

8824/0          Myopericytoma

8824/0                    Myopericytomatosis

8711/0          Glomus tumour, NOS

8711/0                    Classic glomus tumour†

8711/0                    Symplastic glomus tumour†

8711/1                    Glomus tumour of uncertain malignant potential

8711/3                    Glomus tumour, malignant

                     Glomuvenous malformation

 

Smooth muscle tumours

8897/1          EBV-associated smooth muscle tumour

 

Skeletal muscle tumours

                     Rhabdomyoma

8903/0                    Fetal rhabdomyoma

8904/0                    Adult rhabdomyoma

8905/0                    Genital rhabdomyoma

8910/3          Embryonal rhabdomyosarcoma

8910/3                    Anaplastic embryonal rhabdomyosarcoma†

8920/3          Alveolar rhabdomyosarcoma

8901/3          Pleomorphic rhabdomyosarcoma

8912/3          Spindle cell / sclerosing rhabdomyosarcoma

8921/3          Ectomesenchymoma

 

Gastrointestinal stromal tumour

8936/3          Gastrointestinal stromal tumour

8936/3                    Succinate dehydrogenase–deficient gastrointestinal stromal tumour†

 

Peripheral nerve sheath tumours

9560/0          Schwannoma

9560/0                    Ancient schwannoma

9560/0                    Cellular schwannoma

9560/0                    Plexiform schwannoma

9560/0                    Epithelioid schwannoma†

9560/0                    Microcystic/reticular schwannoma†

9540/0          Neurofibroma

9540/0                    Cellular neurofibroma†

9540/1*                  Atypical neurofibroma / atypical neurofibromatous neoplasm of uncertain biological potential†

9550/0                    Plexiform neurofibroma

9540/0                    Diffuse neurofibroma†

9540/0                    Nodular neurofibroma†

9540/0                    Massive soft tissue neurofibroma†

9571/0          Perineurioma

9563/0          Hybrid nerve sheath tumour

9563/0                    Perineurioma/schwannoma†

9563/0                    Neurofibroma/schwannoma†

9563/0                    Perineurioma/neurofibroma†

9580/0          Granular cell tumour

9580/3                    Granular cell tumour, malignant

9570/0          Solitary circumscribed neuroma

9570/0                    Plexiform solitary circumscribed neuroma†

9530/0          Ectopic meningioma†

                     Meningothelial hamartoma

                     Benign triton tumour / neuromuscular choristoma

9540/3          Malignant peripheral nerve sheath tumour, NOS

9542/3                    Malignant peripheral nerve sheath tumour, epithelioid

 

Tumours of uncertain derivation

8840/0          Intramuscular/juxta-articular myxoma†

8841/0          Superficial angiomyxoma

8841/0          Deep angiomyxoma

8836/1          Angiomatoid fibrous histiocytoma

9044/3          Clear cell sarcoma

9581/3          Alveolar soft part sarcoma

8963/3          Extrarenal rhabdoid tumour

8714/0          PEComa

8714/3                    Malignant PEComa

8860/0                    Angiomyolipoma

8860/1                    Angiomyolipoma, epithelioid

9040/3          Synovial sarcoma, NOS

9041/3                    Monophasic synovial sarcoma

9043/3                    Biphasic synovial sarcoma

9040/3                    Poorly differentiated synovial sarcoma†

8804/3          Epithelioid sarcoma

8804/3                    Classic epithelioid sarcoma†

8804/3                    Proximal epithelioid sarcoma†

                     Myoepithelial tumours of soft tissue

8982/0                    Myoepithelioma

8940/0                    Mixed tumour

8982/3                    Myoepithelial carcinoma

8990/0          Phosphaturic mesenchymal tumour, NOS

8990/3                    Phosphaturic mesenchymal tumour, malignant

8806/3          Desmoplastic small round cell tumour

8805/3          Undifferentiated sarcoma, NOS

8801/3                    Undifferentiated spindle cell sarcoma

8802/3                    Undifferentiated pleomorphic sarcoma

8804/3                    Undifferentiated epithelioid sarcoma

 

Undifferentiated small round cell sarcomas of soft tissue and bone

9364/3          Ewing sarcoma

9364/3                    Adamantinoma-like Ewing sarcoma†

9366/3          Round cell sarcoma with EWSR1::non-ETS fusions

9366/3                    Round cell sarcoma with EWSR1/FUS::NFATC2†

9366/3                    Round cell sarcoma with EWSR1::PATZ1†

9367/3          CIC-rearranged sarcoma

9368/3          Sarcoma with BCOR genetic alterations

 

Bone tumours

Osteogenic tumours

9213/0          Subungual exostosis

9212/0          Bizarre parosteal osteochondromatous proliferation

9200/1          Osteoblastoma, NOS

9191/0          Osteoid osteoma, NOS

                     Chondromesenchymal hamartoma of the chest wall

9180/3          Osteosarcoma, NOS

9186/3                    Conventional osteosarcoma

9183/3                    Telangiectatic osteosarcoma

9185/3                    Small cell osteosarcoma

9192/3                    Parosteal osteosarcoma

9193/3                    Periosteal osteosarcoma

9187/3                    Low-grade central osteosarcoma

9194/3                    High-grade surface osteosarcoma

 

Chondrogenic tumours

9230/0          Chondroblastoma, NOS

9210/0          Osteochondroma

9241/0          Chondromyxoid fibroma

9220/0          Enchondroma

9220/1          Enchondromatosis†

9220/1                    Enchondromatosis in Ollier disease†

9220/1                    Enchondromatosis in Maffucci syndrome†

9222/1          Atypical cartilaginous tumour

9222/3          Chondrosarcoma, grade 1

9220/3          Chondrosarcoma, grade 2

9220/3          Chondrosarcoma, grade 3

9221/3          Periosteal chondrosarcoma

9240/3          Mesenchymal chondrosarcoma

 

Other bone tumours

9120/0          Haemangioma, NOS

9121/0                    Cavernous haemangioma

9131/0                    Capillary haemangioma

9120/0                    Angiomatosis†

9125/0          Epithelioid haemangioma

9133/3          Epithelioid haemangioendothelioma

9260/0          Aneurysmal bone cyst

9250/1          Giant cell tumour of bone, NOS

8830/0          Non-ossifying fibroma

                     Notochordal tumours

9370/3                    Conventional chordoma†

9371/3                    Chondroid chordoma

9370/3                    Poorly differentiated chordoma

9370/0                    Benign notochordal cell tumour

9372/3                    Dedifferentiated chordoma

                     Simple bone cyst

9261/3          Adamantinoma of long bones

9261/3                    Classic adamantinoma (malignant)†

9261/1*                  Osteofibrous dysplasia–like adamantinoma

9261/3                    Dedifferentiated adamantinoma†

9261/0*        Osteofibrous dysplasia

8818/0          Fibrous dysplasia

 

ICD-O coding of germ cell tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Non-invasive germ cell neoplasia

9064/2          Intratubular germ cell neoplasia (male gonadal)

9073/1          Gonadoblastoma

 

Germinoma-family tumours

9061/3          Seminoma

9061/3                    Seminoma with syncytiotrophoblast cells†

9060/3          Dysgerminoma

9060/3                    Dysgerminoma with syncytiotrophoblast cells†

9064/3          Germinoma

9064/3                    Germinoma with syncytiotrophoblast cells†

 

Non-germinomatous germ cell tumours

Mature cystic teratoma

9080/0          Teratoma, benign

 

Extragonadal teratoma

                               Sacrococcygeal teratoma

 

Monodermal teratomas (female gonadal)

9090/0          Struma ovarii, NOS

9090/3          Struma ovarii, malignant

9091/1          Strumal carcinoid

9080/0          Monodermal cystic teratoma†

9084/3          Teratoma with malignant transformation

 

Immature teratoma (female gonadal)

9080/3          Immature teratoma, NOS

 

Prepubertal-type testicular teratoma

9084/0          Prepubertal-type testicular teratoma

9084/0                    Dermoid cyst

9084/0                    Epidermoid cyst†

9084/3                    Well-differentiated neuroendocrine tumour (monodermal teratoma)†

 

Postpubertal-type teratoma

9080/3          Teratoma, postpubertal-type

 

Other non-germinomatous germ cell tumours

9070/3          Embryonal carcinoma

9071/3          Yolk sac tumour

9071/3                    Prepubertal (type I) yolk sac tumour

9071/3                    Postpubertal (type II) yolk sac tumour

                     Fetus in fetu

9100/3          Choriocarcinoma (non-gestational)

9085/3          Malignant mixed germ cell tumours

9085/3                    Mixed germinoma and teratoma

9085/3                    Mixed germ cell tumour consisting of germinoma or teratoma with a small portion of malignant element†

9085/3                    Mixed tumour consisting mainly of choriocarcinoma, embryonal carcinoma, or yolk sac tumour

 

ICD-O coding of renal and male genital tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Renal tumours

Nephroblastic and related tumours

8959/0          Paediatric cystic nephroma

8960/3          Nephroblastoma

 

Molecularly defined renal tumours

8311/3          Renal cell carcinoma with MiT translocations

8311/3                    TFE3-rearranged renal cell carcinoma (Xp11 translocation renal cell carcinoma)

8311/3                    TFEB-rearranged renal cell carcinoma (t(6;11) renal cell carcinoma)

8311/3          ALK-rearranged renal cell carcinoma†

8311/3          Eosinophilic solid and cystic renal cell carcinoma†

8510/3          SMARCB1-deficient renal medullary carcinoma†

 

Metanephric tumours

8325/0          Metanephric adenoma

9013/0          Metanephric adenofibroma

8935/1          Metanephric stromal tumour

 

Mesenchymal renal tumours

8967/0          Ossifying renal tumour of infancy

8960/1          Mesoblastic nephroma

8960/1                    Classic mesoblastic nephroma†

8960/1                    Cellular mesoblastic nephroma†

8960/1                    Mixed mesoblastic nephroma†

8964/3          Clear cell sarcoma of the kidney

8963/3          Malignant rhabdoid tumour of the kidney

8802/3          Anaplastic sarcoma of the kidney†

9364/3          Renal Ewing sarcoma

 

Testicular tumours

8622/0          Juvenile granulosa cell tumour of the testis

 

ICD-O coding of female genital tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Ovarian tumours

Sex cord stromal tumours

8810/0          Fibroma, NOS

8810/1                    Cellular fibroma

8602/0          Sclerosing stromal tumour

8622/1          Juvenile granulosa cell tumour of the ovary

8623/1          Sex cord tumour with annular tubules

8450/0          Papillary cystadenoma

8631/1          Sertoli–Leydig cell tumour

8631/0                    Sertoli–Leydig cell tumour, well differentiated

8631/1                    Sertoli–Leydig cell tumour, moderately differentiated

8631/3                    Sertoli–Leydig cell tumour, poorly differentiated

8633/1                    Sertoli–Leydig cell tumour, retiform

8632/1          Gynandroblastoma

 

Other ovarian tumours

8044/3          Small cell carcinoma of the ovary, hypercalcaemic type

8044/3                    Small cell carcinoma of the ovary, hypercalcaemic type, large cell subtype†

 

Lower female genital tract tumours

Epithelial tumours

                     Mesonephric remnants and hyperplasia

                     Müllerian papilloma

                     Condyloma acuminatum

 

Peritoneal tumours

Mesothelial tumours

9055/0          Peritoneal inclusion cysts

 

ICD-O coding of breast tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

9010/0          Fibroadenoma

9020/1          Phyllodes tumour

9030/0          Juvenile fibroadenoma

9030/0                    Giant juvenile fibroadenoma†

                     Juvenile papillomatosis

 

ICD-O coding of digestive system tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Liver tumours

Epithelial tumours

8970/3          Hepatoblastoma, NOS

8970/3                    Pure fetal hepatoblastoma with low mitotic activity (well-differentiated fetal hepatoblastoma)†

8970/3                    Fetal hepatoblastoma, mitotically active (crowded fetal hepatoblastoma)†

8970/3                    Pleomorphic hepatoblastoma, poorly differentiated†

8970/3                    Embryonal hepatoblastoma†

8970/3                    Small cell undifferentiated hepatoblastoma, SMARCB1 (INI1) retained (positive)†

8970/3                    Small cell undifferentiated hepatoblastoma, SMARCB1 (INI1) lost (negative)†

8970/3                    Cholangioblastic hepatoblastoma†

8970/3                    Epithelial mixed hepatoblastoma†

8970/3                    Epithelial macrotrabecular pattern of hepatoblastoma†

8970/3                    Mixed epithelial and mesenchymal hepatoblastoma without teratoid features†

8970/3                    Mixed epithelial and mesenchymal hepatoblastoma with teratoid features†

8000/3                    Hepatoblastoma, hepatocellular neoplasm NOS subtype†

8171/3          Hepatocellular carcinoma, fibrolamellar

8170/3          Hepatocellular carcinoma, NOS

8170/3                    Conventional hepatocellular carcinoma†

8174/3                    Clear cell hepatocellular carcinoma

 

Mesenchymal tumours unique to the liver

                     Mesenchymal hamartoma

8975/1          Calcifying nested stromal-epithelial tumour

8991/3          Embryonal sarcoma

9131/0          Congenital haemangioma

9131/0                    Rapidly involuting congenital haemangioma†

9131/0                    Partially involuting congenital haemangioma

9131/0                    Non-involuting congenital haemangioma

9131/0          Infantile haemangioma

9131/0                    Single infantile haemangioma†

9131/0                    Multifocal infantile haemangioma†

9131/0                    Diffuse infantile haemangioma†

9120/3          Angiosarcoma

 

Pancreatic tumours

Epithelial tumours

8971/3          Pancreatoblastoma

8550/3          Acinar cell carcinoma

8551/3                    Acinar cell cystadenocarcinoma

8452/3          Solid pseudopapillary neoplasm of the pancreas

8452/3                    Solid pseudopapillary neoplasm with high-grade carcinoma†

 

Gastrointestinal tumours

Epithelial tumours

8976/1          Gastroblastoma

8240/3          Neuroendocrine tumour, NOS

8240/3          Neuroendocrine tumour, grade 1

8249/3          Neuroendocrine tumour, grade 2

 

ICD-O coding of endocrine tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Thyroid tumours

Thyroid epithelial tumours

8330/0          Follicular thyroid adenoma

8330/0                    Follicular thyroid adenoma with papillary architecture†

8330/0                    Hyperfunctioning (toxic) follicular adenoma†

8290/0                    Oncocytic adenoma of the thyroid

8260/3          Papillary thyroid carcinoma

8340/3                    Follicular variant of papillary thyroid carcinoma

8350/3                    Diffuse sclerosing papillary thyroid carcinoma

8260/3                    Solid/trabecular papillary thyroid carcinoma†

8344/3                    Tall cell papillary thyroid carcinoma

8342/3                    Oncocytic papillary thyroid carcinoma

8341/3          Papillary thyroid microcarcinoma

8201/3          Cribriform carcinoma, NOS

8345/3          Medullary thyroid carcinoma

8345/3                    Medullary thyroid microcarcinoma

8588/3          Spindle epithelial tumour with thymus-like elements

 

Parathyroid tumours

Parathyroid endocrine tumours

8140/0          Parathyroid adenoma

 

Adrenal tumours

Adrenal cortical tumours

8370/0          Adrenal cortical adenoma

8370/3          Adrenal cortical carcinoma

 

Tumours of the adrenal medulla and extra-adrenal paraganglia

8681/3          Sympathetic paraganglioma

8682/3          Parasympathetic paraganglioma (head and neck paraganglioma)

8700/3          Phaeochromocytoma

8700/3          Composite paraganglion tumours†

8700/3                    Composite phaeochromocytoma-ganglioneuroma†

8700/3                    Composite phaeochromocytoma-ganglioneuroblastoma†

8700/3                    Composite phaeochromocytoma-neuroblastoma†

8700/3                    Composite phaeochromocytoma–peripheral nerve sheath tumour†

8693/3          Extra-adrenal composite paraganglion tumours†

8693/3                    Composite paraganglioma-neuroblastoma†

8693/3                    Composite paraganglioma-ganglioneuroblastoma†

 

Neuroendocrine neoplasms

Neuroendocrine tumours

8240/3          Neuroendocrine tumour, grade 1

8249/3          Neuroendocrine tumour, grade 2

8151/3          Insulinoma

 

ICD-O coding of head and neck tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Benign tumours

8052/0          Squamous papilloma of the larynx

8060/0          Squamous papillomatosis of the larynx

                     White sponge naevus

                     Congenital granular cell epulis

                     Central giant cell granuloma

 

Odontogenic tumours

9310/0          Ameloblastoma

9330/0          Ameloblastic fibroma

9300/0          Adenomatoid odontogenic tumour

9280/0          Odontoma

9320/0          Odontogenic myxoma

                     Odontogenic keratocyst

 

Other benign tumours

9262/0          Ossifying fibroma

9262/0                    Juvenile trabecular ossifying fibroma†

9262/0                    Psammomatoid ossifying fibroma†

8840/0          Sinonasal tract myxoma

                     Nasal dermoid cyst

                     Hairy polyp

                     Nasal chondromesenchymal hamartoma

8940/0          Pleomorphic adenoma

 

Malignant tumours

8430/3          Mucoepidermoid carcinoma

8430/3                    Oncocytic mucoepidermoid carcinoma†

8430/3                    Warthin-like mucoepidermoid carcinoma†

8550/3          Acinic cell carcinoma

8974/1          Sialoblastoma

8070/3          Nasopharyngeal carcinoma†

8071/3                    Squamous cell carcinoma, keratinizing, NOS

8072/3                    Squamous cell carcinoma, non-keratinizing, NOS

8083/3                    Basaloid squamous cell carcinoma

8023/3          NUT carcinoma

9363/1          Melanotic neuroectodermal tumour, NOS

9363/3          Melanotic neuroectodermal tumour, malignant

 

ICD-O coding of thoracic tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Lung tumours

                     Fetal lung interstitial tumour

8827/1          Congenital peribronchial myofibroblastic tumour

8973/3          Pleuropulmonary blastoma

8973/3                    Pleuropulmonary blastoma, type I†

8973/3                    Pleuropulmonary blastoma, type Ir†

8973/3                    Pleuropulmonary blastoma, type II†

8973/3                    Pleuropulmonary blastoma, type III†

 

Heart tumours

8900/0          Cardiac rhabdomyoma

 

ICD-O coding of skin tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                   Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Hamartomas

 

Epithelial neoplasms

Squamous neoplasms

9141/0          Angiokeratoma

                     Epidermal naevus

8110/0          Pilomatricoma

 

Melanocytic neoplasms

Naevi

8761/0          Congenital naevus

8761/0                    Congenital naevus present at birth†

8761/0                    Late/tardive congenital naevus†

8740/0          Junctional naevus

8760/0          Compound naevus

8750/0          Dermal naevus

8780/0          Blue naevus, NOS

8790/0                    Cellular blue naevus

8780/0                    Dendritic blue naevus†

8770/0          Spitz naevus

8770/0                    Intradermal Spitz naevus†

8770/0                    Pagetoid Spitz naevus†

8770/0                    Dysplastic Spitz naevus†

8770/0                    Desmoplastic Spitz naevus†

8770/0                    Angiomatoid Spitz naevus†

8770/0                    Hyalinizing Spitz naevus†

8770/0                    Plexiform Spitz naevus†

8770/0                    Tubular Spitz naevus†

8770/0                    Myxoid Spitz naevus†

8770/0                    Balloon cell Spitz naevus†

8770/0                    Pigmented epithelioid cell Spitz naevus†

8770/0                    Combined Spitz naevus†

8770/0                    Recurrent/persistent Spitz naevus†

8770/0          Pigmented spindle cell naevus (Reed naevus)

 

Melanoma

                     Melanoma

8761/3                    Congenital naevus–associated melanoma†

8770/3                    Spitz melanoma

8743/3                    Conventional low-CSD melanoma†

8780/3                    Melanoma arising in blue naevus

8728/0                    Meningeal melanocytosis

8728/3                    Meningeal melanomatosis

 

 

Notes
These morphology codes are from the International Classification of Diseases for Oncology, third edition, second revision (ICD-O-3.2) [[International Association of Cancer Registries (IACR) [Internet]. Lyon (France): International Agency for Research on Cancer; 2021. International Classification of Diseases for Oncology (ICD-O) – ICD-O-3.2; updated 2021 Jan 25. Available from: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577.]]. Behaviour is coded /0 for benign tumours; /1 for unspecified, borderline, or uncertain behaviour; /2 for carcinoma in situ and grade III intraepithelial neoplasia; /3 for malignant tumours, primary site; and /6 for malignant tumours, metastatic site. Behaviour code /6 is not generally used by cancer registries.

This classification is modified from the previous WHO classification, taking into account changes in our understanding of these lesions.

n/a, not available (provisional entity or subtype).

* Codes marked with an asterisk were approved by the IARC/WHO Committee for ICD-O at its meeting in Feb 2022, or during subsequent consultation.

† Labels marked with a dagger have undergone a change in terminology of a previous code.